Discovery of the sEH Inhibitor Epoxykynin as a Potent Kynurenine Pathway Modulator. Read more about Discovery of the sEH Inhibitor Epoxykynin as a Potent Kynurenine Pathway Modulator.
Structure-guided drug discovery: back to the future. Read more about Structure-guided drug discovery: back to the future.
Discovery of Conformationally Constrained ALK2 Inhibitors. Read more about Discovery of Conformationally Constrained ALK2 Inhibitors.
Chemical tools for the Gid4 subunit of the human E3 ligase C-terminal to LisH (CTLH) degradation complex. Read more about Chemical tools for the Gid4 subunit of the human E3 ligase C-terminal to LisH (CTLH) degradation complex.
Illumination of understudied ciliary kinases. Read more about Illumination of understudied ciliary kinases.
Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor. Read more about Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor.
Synthesis of 5-Benzylamino and 5-Alkylamino-Substituted Pyrimido[4,5-c]quinoline Derivatives as CSNK2A Inhibitors with Antiviral Activity. Read more about Synthesis of 5-Benzylamino and 5-Alkylamino-Substituted Pyrimido[4,5-c]quinoline Derivatives as CSNK2A Inhibitors with Antiviral Activity.
A guide to selecting high-performing antibodies for Rab1A and Rab1B for use in Western Blot, immunoprecipitation and immunofluorescence. Read more about A guide to selecting high-performing antibodies for Rab1A and Rab1B for use in Western Blot, immunoprecipitation and immunofluorescence.
Loss-of-function mutation in PRMT9 causes abnormal synapse development by dysregulation of RNA alternative splicing. Read more about Loss-of-function mutation in PRMT9 causes abnormal synapse development by dysregulation of RNA alternative splicing.
Identification and structural characterization of small molecule inhibitors of PINK1. Read more about Identification and structural characterization of small molecule inhibitors of PINK1.
